Long-term pattern of HIV-1 RNA load in perinatally infected children

Scand J Infect Dis. 1999;31(4):337-43. doi: 10.1080/00365549950163743.

Abstract

The objective of this study was to describe the natural history of HIV-1 RNA load in vertically HIV-1-infected children. HIV-1 RNA in 156 plasma or serum samples (1-14, median 4 from each child) from 32 vertically HIV-1-infected children was detected with the NASBA technique (Organon Teknika, The Netherlands). Twenty-one children were prospectively followed from birth, and 11 were identified and included at the age of 7-89 (median 61) months. The highest numbers of HIV-1 RNA copies were seen at 1.5-3 months of age. A quadratic curve model showed a reduction of HIV-1 RNA with increasing age up to approximately 8 years, and thereafter increasing numbers, p(age) = 0.002, p(age2) = 0.008. This pattern was not typical for individual children in whom a great variation in HIV-1 RNA numbers was seen over time. The interval from birth to the first HIV-1 RNA peak ranged from 1.5 months to more than 2 years. The HIV-1 RNA levels remained relatively high and fluctuating over the years in symptomatic as well as in long-term asymptomatic children. This makes HIV-1 RNA determination in children more difficult to use than in adults, as the only tool for prediction of disease progression and for initiation of therapy.

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • CD4 Lymphocyte Count
  • Child, Preschool
  • Disease Progression
  • Female
  • Follow-Up Studies
  • HIV Infections / drug therapy
  • HIV Infections / immunology
  • HIV Infections / transmission*
  • HIV Infections / virology*
  • HIV-1 / isolation & purification*
  • Humans
  • Incidence
  • Infant
  • Infant, Newborn
  • Infectious Disease Transmission, Vertical* / statistics & numerical data
  • Linear Models
  • Male
  • Monitoring, Physiologic
  • Pregnancy
  • Prospective Studies
  • RNA, Viral / analysis
  • Risk Factors
  • Sensitivity and Specificity
  • Statistics, Nonparametric
  • Sweden
  • Viral Load
  • Viremia / drug therapy
  • Viremia / immunology
  • Viremia / transmission*
  • Viremia / virology*
  • Zidovudine / therapeutic use

Substances

  • RNA, Viral
  • Zidovudine